StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.00−0.02 (-0.66%)

Close on Nov 17, 2026Market cap $519.43MP/E –Yield –

Entera Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Entera Bio's price to book ratio was 21.8× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 1.3× to 21.8×, with a median of 4.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.8×+16.0
2025Dec 31, 20255.8×−6.2
2024Dec 31, 202412.0×+9.2
2023Dec 29, 20232.8×+1.3
2022Dec 30, 20221.5×−1.6
2021Dec 31, 20213.0×+0.8
2020Jul 31, 20202.2×–

More Entera Bio figures

See a number that looks wrong?